GDF15 and cardiomyopathy: Similarly elevated soluble suppression of tumorigenicity-2 (sST2), growth differentiation factor-15 (GDF-15) and NT-proBNP may predict biventricular ACM, but no data are available in the context of “Hot phase” cardiomyopathy.